Skip to main content

$0.021 -0.004 (-16.00%)

High

$0.02

Low

$0.02

Trades

6

Turnover

$1,157

Volume

54,409
30 June 2023 at 2:56pm
Register to track TRU and receive email alerts.
Subject
TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice

TRU Ann: Dr Beata Edling Appointed CEO of TruScreen Group

TRU Ann: Dr Beata Edling Appointed CEO of TruScreen Group

TRU Ann: Results of Meeting

TRU Ann: Results of Meeting

TRU Ann: Annual Shareholder Meeting Presentation

TRU Ann: Annual Shareholder Meeting Presentation

TRU Ann: Signs 5 Year Manufacturing Agreement for Critical SUS Supply

TRU Ann: Signs 5 Year Manufacturing Agreement for Critical SUS Supply

TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice

TRU Ann: Relaunch of TruScreen Devices in Xinjiang Uygur Region

TRU Ann: Relaunch of TruScreen Devices in Xinjiang Uygur Region

TRU Ann: TRU based Cervical Cancer Screening Clinic Opens Mexico City

TRU Ann: TRU based Cervical Cancer Screening Clinic Opens Mexico City

TRU Ann: Notice of Annual General Meeting/Proxy Form

TRU Ann: Notice of Annual General Meeting/Proxy Form

TRU Ann: Director Nominations Closing Date

TRU Ann: Director Nominations Closing Date

TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice

TRU Ann: Annual Report to shareholders

TRU Ann: Annual Report to shareholders

TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice

TRU Ann: Change of Director's Interest Notice X 2

TRU Ann: Change of Director's Interest Notice X 2

TRU Ann: Preliminary Final Report

TRU Ann: Preliminary Final Report

TRU Ann: Provision for Impairment of Non Current Assets

TRU Ann: Provision for Impairment of Non Current Assets

TRU Ann: COGA Trial Validates TRU Cervical Cancer Screening Method

TRU Ann: COGA Trial Validates TRU Cervical Cancer Screening Method

TRU Ann: Issue of Options - Capital Change Notice

TRU Ann: Issue of Options - Capital Change Notice

TRU Ann: TruScreen Achieves Significant Milestones with Distributors

TRU Ann: TruScreen Achieves Significant Milestones with Distributors

TRU Ann: Change of Directors Interest Notice X 2

TRU Ann: Change of Directors Interest Notice X 2

TRU Ann: Issue of Options - Capital Change Notice

TRU Ann: Issue of Options - Capital Change Notice

TRU Ann: TruScreen Makes Progress in Key Markets Worldwide

TRU Ann: TruScreen Makes Progress in Key Markets Worldwide

TRU Ann: Half Year Accounts

TRU Ann: Half Year Accounts

Register to track TRU and receive email alerts.